论文部分内容阅读
目的观察布地奈德联合特布他林雾化吸入治疗毛细支气管炎的临床疗效。方法将70例毛细支气管炎患儿随机分为治疗组和对照组各35例。两组均采用抗病毒、吸氧、止咳、镇静等对症治疗,治疗组在此基础上每天雾化吸入布地奈德和特布他林雾化液,对照组吸入α-糜蛋白酶。比较两组的疗效及主要临床症状、体征消失时间。结果治疗组的总有效率明显优于对照组,差异有显著性(P<0.05);治疗组主要临床症状、体征消失时间明显短于对照组,具有显著的统计学意义(P<0.05)。结论雾化吸入布地奈德和特布他林治疗毛细支气管炎疗效显著,是治疗毛细支气管炎的首选方法之一。
Objective To observe the clinical efficacy of budesonide combined with terbutaline in the treatment of bronchiolitis. Methods 70 cases of bronchiolitis were randomly divided into treatment group and control group of 35 cases. Both groups used symptomatic treatment such as antivirus, oxygen inhalation, cough and sedation. On the basis of this, the treatment group inhaled budesonide and terbutaline nebulizer daily while the control group inhaled α-chymotrypsin. The curative effect and the main clinical symptoms were compared between the two groups and the signs disappeared. Results The total effective rate of the treatment group was significantly better than that of the control group (P <0.05). The clinical symptoms and signs disappeared in the treatment group were significantly shorter than those in the control group (P <0.05). Conclusion The inhalation of budesonide and terbutaline for the treatment of bronchiolitis significant effect, is the treatment of bronchiolitis preferred method.